Benign prostatic hyperplasia epidemiology and demographics

	Benign prostatic hyperplasia Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Benign Prostatic Hyperplasia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Benign prostatic hyperplasia epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Benign prostatic hyperplasia epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Benign prostatic hyperplasia epidemiology and demographics
CDC on Benign prostatic hyperplasia epidemiology and demographics
Benign prostatic hyperplasia epidemiology and demographics in the news
Blogs on Benign prostatic hyperplasia epidemiology and demographics
Directions to Hospitals Treating Benign prostatic hyperplasia
Risk calculators and risk factors for Benign prostatic hyperplasia epidemiology and demographics

Steven C. Campbell, M.D., Ph.D.

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview[edit | edit source]

More than half of the men in the United States between the ages of 60 and 70 and as many as 90% between the ages of 70 and 90 have symptoms of BPH. For some men, the symptoms may be severe enough to require treatment.

References[edit | edit source]

Template:WH Template:WS